CareLit · DOI-Nachweis · Pneumologie
Efficacy of combination treatment with Omalizumab and specific immunotherapy (Depigoid®) in adult and adolescent patients with seasonal allergic asthma and comorbid seasonal allergic rhinoconjunctivitis
DOI 10.1055/s-2007-973306
Bibliografische Angaben
Nachweis in CareLit
Autor:innenM Kopp, S Seyfried, S Stenglein, C Sieder, K Bergmann, U Wahn
ZeitschriftPneumologie
Ausgabe03/2007
Jahrgang / SeitenNicht angegeben
Kernaussage aus der Literatur
Abstract-Vorschau
Background: Previous study data generated in patients with grass- and birch-pollen allergic seasonal rhinoconjunctivitis has demonstrated a statistically significant and clinically relevant superiority of the combination of Xolair® (Omalizumab) plus SIT versus SIT monotherapy. There is no data available of anti-IgE treatment in seasonal allergic asthma nor on its efficacy on SIT long-term treatment (improved immunmo…
Zitieren
Zitierempfehlung
M Kopp, S Seyfried, S Stenglein, C Sieder, K Bergmann, U Wahn (2007) Efficacy of combination treatment with Omalizumab and specific immunotherapy (Depigoid®) in adult and adolescent patients with seasonal allergic asthma and comorbid seasonal allergic rhinoconjunctivitis. Pneumologie (03). https://doi.org/10.1055/s-2007-973306
Mit CareLit weiterarbeiten